IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Assisting HIV-infected Mothers in Disclosing Their Serostatus to Their Children (TRACK)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
| Condition | Intervention | Phase |
|---|---|---|
| HIV | Behavioral: Teaching, Raising, and Communicating with Kids (TRACK) Other: Treatment as usual | Phase 1 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Single Group Assignment Masking: Single (Outcomes Assessor) |
| Official Title: | Maternal HIV: Intervention to Assist Disclosure to Children |
- Readiness to disclose HIV serostatus [ Time Frame: Measured at Months 3, 6, and 9 ]
- Disclosure of HIV serostatus [ Time Frame: Measured at Months 3, 6, and 9 ]
- Mothers' mental health indicators [ Time Frame: Measured at Months 3, 6, and 9 ]
- Children's mental health indicators [ Time Frame: Measured at Months 3, 6, and 9 ]
- Children's behavioral problems [ Time Frame: Measured at Months 3, 6, and 9 ]
- Parent-child relationship and family functioning [ Time Frame: Measured at Months 3, 6, and 9 ]
| Enrollment: | 160 |
| Study Start Date: | September 2007 |
| Study Completion Date: | January 2010 |
| Primary Completion Date: | January 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Intervention
Participants will receive a cognitive-behavioral intervention designed to improve mother-child communication and parenting skills and prepare caregiver for disclosure of HIV serostatus to child
|
Behavioral: Teaching, Raising, and Communicating with Kids (TRACK)
TRACK is cognitive-behavioral treatment designed to improve mother-child communication and parenting skills and prepare caregiver for disclosure of HIV serostatus to child. The treatment consists of three 75-minute sessions that focus on exploring mothers' concerns, determining children's readiness to receive the news, planning for disclosure, and practicing disclosure.
|
|
Active Comparator: Control
Participants will receive treatment as usual
|
Other: Treatment as usual
Treatment as usual includes standard care for HIV infected mothers.
|
Detailed Description:
HIV is a serious, life threatening illness that requires a lifetime of treatment and disease management. Studies have shown that it can be very difficult for infected mothers to decide whether and/or when to disclose their HIV serostatus to their uninfected children. HIV-infected parents struggle with the fear that their children will be forced to grow up too quickly, become worried or depressed, or be angry with their parents once they learn that their parents have HIV. Family-based intervention programs have been successful in helping facilitate the disclosure process. This study will develop and evaluate the effectiveness of an intervention designed to assist HIV-infected mothers of young children in determining whether and how to appropriately disclose their HIV serostatus to their children.
Participants in this study will be randomly assigned to either the intervention or a standard of care condition. The intervention will consist of three 75-minute sessions that will focus on exploring mothers' concerns, determining children's readiness to receive the news, planning for disclosure, and practicing disclosure. Participants will also receive one follow-up phone call from the therapist about 3 weeks after the last session. Sessions will be scheduled at times that are convenient for the participants and therapists. Follow-up visits will include both mothers and their children, and will be held at Months 3, 6, and 9 following the end of the intervention. Assessments will include readiness to disclose HIV serostatus, mental health indicators, and family functioning.
Eligibility| Ages Eligible for Study: | 6 Years to 65 Years (Child, Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Confirmation of mother's HIV/AIDS status
- Healthy child (i.e., HIV uninfected) who is between 6 and 12 years of age and is unaware of maternal serostatus
- Mother is primary caregiver and child resides with her
- English- or Spanish-speaking
Exclusion Criteria:
- Child does not meet screening criteria (e.g., diagnosed with depression or suicide attempt, IQ score less than 75)
- Psychosis of parent or child (as advised by recruitment site clinicians)
- Child refuses to give assent
Contacts and LocationsPlease refer to this study by its ClinicalTrials.gov identifier: NCT00429546
| United States, California | |
| University of California, Los Angeles | |
| Los Angeles, California, United States, 90025 | |
| Principal Investigator: | Debra A. Murphy, PhD | University of California, Los Angeles |
More Information
| Responsible Party: | Debra A. Murphy, Ph.D., Professor in Residence, University of California, Los Angeles |
| ClinicalTrials.gov Identifier: | NCT00429546 History of Changes |
| Other Study ID Numbers: |
R01MH077493 ( U.S. NIH Grant/Contract ) DAHBR 9A-ASAP |
| Study First Received: | January 29, 2007 |
| Last Updated: | June 24, 2013 |
Keywords provided by Debra A. Murphy, Ph.D., University of California, Los Angeles:
|
Disclosure Serostatus |
ClinicalTrials.gov processed this record on September 21, 2017